We are live on ! Find out more
AKCA

Akcea Therapeutics Inc
AKCA

Delisted

AKCA was delisted on the 9th of October, 2020.

Back to rankings

75 hedge funds and large institutions have $354M invested in Akcea Therapeutics Inc in 2019 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 26 increasing their positions, 19 reducing their positions, and 7 closing their positions.

New
Increased
Maintained
Reduced
Closed

186% more first-time investments, than exits

New positions opened: 20 | Existing positions closed: 7

37% more repeat investments, than reductions

Existing positions increased: 26 | Existing positions reduced: 19

21% more funds holding

Funds holding: 62 → 75 (+13)

5% more capital invested

Capital invested by funds: $338M → $354M (+$15.9M)

38% less call options, than puts

Call options by funds: $1.98M | Put options by funds: $3.18M

Holders
75
Holders Change
+13
Holders Change %
+20.97%
% of All Funds
1.48%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
20
Increased
26
Reduced
19
Closed
7
Calls
$1.98M
Puts
$3.18M
Net Calls
-$1.2M
Net Calls Change
+$260K

Top Buyers

Rank Fund Capital Flow
1
Citadel Advisors
Citadel Advisors
Florida
+$4.88M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$4.71M
3
Squarepoint
Squarepoint
New York
+$2.24M
4
D.E. Shaw & Co
D.E. Shaw & Co
New York
+$2.05M
5
Millennium Management
Millennium Management
New York
+$1.54M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$16.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$10.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
-$6.47M
4
Morgan Stanley
Morgan Stanley
New York
-$3.98M
5
SC
Sculptor Capital
New York
-$3.38M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$183M -$10.1M -544,146 -5%
BG
2
Bellevue Group
Switzerland
$53.6M +$981K +52,732 +2%
BlackRock
3
BlackRock
New York
$31.5M -$1.18M -63,446 -3%
Vanguard Group
4
Vanguard Group
Pennsylvania
$22.9M -$6.47M -347,678 -20%
State Street
5
State Street
Massachusetts
$11.3M +$888K +47,729 +8%
Citadel Advisors
6
Citadel Advisors
Florida
$4.91M +$4.88M +262,312 +959%
Point72 Asset Management
7
Point72 Asset Management
Connecticut
$4.29M +$4.71M +253,200 New
Geode Capital Management
8
Geode Capital Management
Massachusetts
$4.26M -$110K -5,920 -2%
Northern Trust
9
Northern Trust
Illinois
$3.28M -$37.2K -2,001 -1%
AA
10
ALPS Advisors
Colorado
$3.2M +$67.5K +3,626 +2%
D.E. Shaw & Co
11
D.E. Shaw & Co
New York
$2.83M +$2.05M +109,992 +194%
Charles Schwab
12
Charles Schwab
California
$2.58M +$842K +45,245 +42%
Squarepoint
13
Squarepoint
New York
$2.44M +$2.24M +120,321 +513%
Russell Investments Group
14
Russell Investments Group
United Kingdom
$1.88M +$915K +49,152 +80%
Goldman Sachs
15
Goldman Sachs
New York
$1.45M +$403K +21,651 +34%
Millennium Management
16
Millennium Management
New York
$1.4M +$1.54M +82,646 New
AGA
17
Altrinsic Global Advisors
Connecticut
$1.19M -$930K -50,000 -42%
Renaissance Technologies
18
Renaissance Technologies
New York
$1.19M +$1.31M +70,200 New
Nuveen
19
Nuveen
North Carolina
$1.04M -$52.3K -2,812 -4%
Susquehanna International Group
20
Susquehanna International Group
Pennsylvania
$1.03M +$1.13M +60,594 New
MFAM
21
Motley Fool Asset Management
Virginia
$1.02M -$38.5K -2,068 -3%
Bank of New York Mellon
22
Bank of New York Mellon
New York
$980K +$38.9K +2,091 +4%
ARTA
23
A.R.T. Advisors
New York
$907K +$459K +24,653 +85%
Wells Fargo
24
Wells Fargo
California
$830K +$437K +23,504 +92%
Tudor Investment Corp
25
Tudor Investment Corp
Connecticut
$787K +$73.9K +3,973 +9%
1
2 3 4

AKCA Hedge Fund Activity: Q4 2019 in Review

75 of the 5,076 institutional investors tracked by Wall St. Rank reported a position in Akcea Therapeutics Inc (AKCA) for Q4 2019, worth a combined $354M — up 4.7% from $338M a quarter earlier.

Buyers outnumbered sellers: 20 funds opened new AKCA positions and 7 closed out — a net gain of 13 holders — while 26 added to existing stakes and 19 trimmed.

The largest buyer was Citadel Advisors, adding an estimated $4.88M. The largest seller was Wellington Management Group, exiting entirely with an estimated $16.5M sold.

  • 75 institutional investors held Akcea Therapeutics Inc (AKCA) as of Q4 2019, up from 62 in Q3 2019.
  • Funds reported $354M of Akcea Therapeutics Inc stock for Q4 2019, up 4.7% quarter-over-quarter.
  • 20 funds opened new Akcea Therapeutics Inc positions in Q4 2019 and 7 closed out, a net change of +13 holders.
  • The largest Akcea Therapeutics Inc buyer in Q4 2019 was Citadel Advisors, an estimated $4.88M added.
  • The largest Akcea Therapeutics Inc seller in Q4 2019 was Wellington Management Group, an estimated $16.5M sold.

Based on aggregated 13F filings for Q4 2019.